- Industry
- 1 min read
About 4 million Americans got updated COVID vaccines in September
The updated shots from Pfizer and BioNTech or Moderna are single-target vaccines aimed at the XBB.1.5 Omicron subvariant of the coronavirus, which was dominant in the U.S. for much of this year but has since been overtaken by other variants as the virus evolves.
"The Biden-Harris Administration, through HHS, has been working directly with manufacturers and distributors to ensure that the vaccines are getting to pharmacies, hospitals, clinics, and other vaccination sites, including long-term care facilities as quickly as possible," a spokesperson for the department said in an emailed statement.
The updated shots from Pfizer and BioNTech or Moderna are single-target vaccines aimed at the XBB.1.5 Omicron subvariant of the coronavirus, which was dominant in the U.S. for much of this year but has since been overtaken by other variants as the virus evolves.
Another updated COVID shot, made by Novavax, was authorized on Tuesday but is not yet available.
Rollout of the Pfizer and Moderna shots began in earnest after the U.S. Centers for the Disease Control and Prevention (CDC) recommended them on Sept. 12. The rollout of last year's updated shots targeting two virus variants started about 10 days earlier, and by Sept. 21, around 4.4 million Americans had rolled up their sleeves for one of them.
U.S. public health officials have expressed hope that Americans will welcome the new vaccines as they would an annual flu shot. But demand for COVID vaccines has dropped sharply since 2021, when they first became available.
Around 56.5 million people, or 17% of the U.S. population, received last year's version of the vaccines.
COMMENTS
All Comments
By commenting, you agree to the Prohibited Content Policy
PostBy commenting, you agree to the Prohibited Content Policy
PostFind this Comment Offensive?
Choose your reason below and click on the submit button. This will alert our moderators to take actions